flavonoid
ubiquit
photosynthesis
cell
commonli
found
fruit
veget
nut
seed
stem
flower
tea
wine
propoli
honey
centuri
prepar
contain
compound
princip
physiolog
activ
constitu
use
treat
human
diseas
increasingli
class
natur
product
becom
subject
antiinfect
research
mani
group
isol
identifi
structur
flavonoid
possess
antifung
antivir
antibacteri
activ
moreov
sever
group
demonstr
synergi
activ
flavonoid
well
flavonoid
exist
chemotherapeut
report
activ
field
antibacteri
flavonoid
research
wide
conflict
probabl
owe
interand
intraassay
variat
suscept
test
howev
sever
highqual
investig
examin
relationship
flavonoid
structur
antibacteri
activ
close
agreement
addit
numer
research
group
sought
elucid
antibacteri
mechan
action
select
flavonoid
activ
quercetin
exampl
least
partial
attribut
inhibit
dna
gyras
also
propos
sophoraflavon
g
epigallocatechin
gallat
inhibit
cytoplasm
membran
function
licochalcon
c
inhibit
energi
metabol
flavonoid
whose
mechan
action
investig
includ
robinetin
myricetin
apigenin
rutin
galangin
methylchalcon
lonchocarpol
compound
repres
novel
lead
futur
studi
may
allow
develop
pharmacolog
accept
antimicrobi
agent
class
agent
resist
antimicrobi
agent
becom
increasingli
import
press
global
problem
million
peopl
acquir
bacteri
infect
us
hospit
year
case
involv
strain
resist
least
one
drug
major
caus
concern
uk
methicillinresist
staphylococcu
aureu
mrsa
low
level
decad
ago
account
ca
aureu
isol
substanti
invest
research
field
antiinfect
desper
need
public
health
crisi
avert
structur
modif
antimicrobi
drug
resist
develop
proven
effect
mean
extend
lifespan
antifung
agent
azol
antivir
agent
nonnucleosid
revers
transcriptas
inhibitor
variou
antibacteri
agent
includ
quinolon
surpris
respons
antimicrobi
resist
major
pharmaceut
compani
tend
concentr
effort
improv
antimicrobi
agent
establish
class
howev
portfolio
chemotherapeut
current
avail
acknowledg
research
get
close
end
game
term
parent
structur
alter
call
therefor
made
develop
new
class
drug
work
differ
target
site
current
use
ration
drug
design
alway
yield
effect
antimicrobi
past
potent
enzym
inhibitor
success
design
synthesis
modest
antibacteri
activ
probabl
owe
complex
issu
drug
uptak
cell
broad
empir
screen
chemic
entiti
antimicrobi
activ
repres
altern
strategi
develop
novel
drug
natur
product
particularli
rich
sourc
antiinfect
agent
yield
exampl
penicillin
tetracyclin
glycopeptid
follow
review
examin
antimicrobi
activ
flavonoid
class
natur
product
possess
divers
rang
pharmacolog
properti
compound
antifung
antivir
antibacteri
activ
discuss
turn
particular
emphasi
flavonoid
antibacteri
activ
flavonoid
ubiquit
photosynthesis
cell
therefor
occur
wide
plant
kingdom
found
fruit
veget
nut
seed
stem
flower
well
tea
wine
propoli
honey
repres
common
constitu
human
diet
us
daili
dietari
intak
mix
flavonoid
estim
rang
mg
figur
high
sever
gram
peopl
supplement
diet
flavonoid
flavonoidcontain
herbal
prepar
function
flavonoid
flower
provid
colour
attract
plant
pollin
leav
compound
increasingli
believ
promot
physiolog
surviv
plant
protect
exampl
fungal
pathogen
uvb
radiat
addit
flavonoid
involv
photosensitis
energi
transfer
action
plant
growth
hormon
growth
regul
control
respir
photosynthesi
morphogenesi
sex
determin
basic
structur
featur
flavonoid
compound
pyran
flavan
nucleu
consist
two
benzen
ring
b
link
heterocycl
pyran
ring
c
fig
flavonoid
classifi
accord
biosynthet
origin
class
exampl
chalcon
flavanon
intermedi
biosynthesi
well
end
product
accumul
plant
tissu
class
known
end
product
biosynthesi
exampl
anthocyanidin
proanthocyanidin
flavon
flavonol
two
addit
class
flavonoid
side
chain
flavanon
isomeris
posit
give
rise
isoflavon
relat
isoflavonoid
neoflavonoid
form
isomeris
posit
structur
major
class
flavonoid
given
fig
structur
specif
compound
within
class
possess
antimicrobi
activ
discuss
present
review
summaris
tabl
individu
flavonoid
may
assign
name
three
differ
way
trivial
name
employ
extens
sometim
indic
flavonoid
class
plant
sourc
exampl
name
end
inidin
denot
anthocyanidin
name
end
etin
gener
denot
flavonol
compound
tricin
hypolaetin
extract
plant
belong
genera
triticum
hypolaena
flavonoid
may
also
name
semisystemat
manner
base
trivial
name
flavon
chalcon
parent
structur
eg
pentahydroxyflavon
lastli
flavonoid
may
given
systemat
chemic
name
eg
flavan
method
cumbersom
rare
use
present
review
trivial
name
use
wherev
possibl
increasingli
flavonoid
becom
subject
medic
research
report
possess
mani
use
properti
includ
antiinflammatori
activ
oestrogen
activ
enzym
inhibit
antimicrobi
activ
antiallerg
activ
antioxid
activ
vascular
activ
cytotox
antitumour
activ
group
compound
rel
homogen
structur
flavonoid
inhibit
perplex
number
varieti
eukaryot
enzym
tremend
wide
rang
activ
case
enzym
inhibit
postul
due
interact
enzym
differ
part
flavonoid
molecul
eg
carbohydr
phenyl
ring
phenol
benzopyron
ring
sever
review
written
interact
flavonoid
mammalian
cell
includ
comprehens
articl
harborn
william
middleton
et
al
extens
review
biochemistri
medic
signific
flavonoid
also
recent
produc
havsteen
centuri
prepar
contain
flavonoid
princip
physiolog
activ
constitu
use
physician
lay
healer
attempt
treat
human
diseas
exampl
plant
taget
minuta
contain
use
extens
argentin
folk
medicin
treat
infecti
diseas
heal
properti
propoli
tzori
hebrew
refer
throughout
old
testament
balm
prescrib
hippocr
bc
ancient
greec
treatment
sore
ulcer
isoflavon
chalcon
flavanon
flavon
flavonol
anthocyanidin
proanthocyanidin
occur
dimer
trimer
tetram
pentam
r
structur
flavan
dihydrochalcon
tabl
summari
structur
antimicrobi
flavonoid
discuss
within
present
review
articl
compil
handbook
natur
flavonoid
individu
research
paper
substitu
carbon
posit
flavon
glycosid
acacetin
galangin
anthocyanidin
leucocyanidin
antimicrobi
properti
propoli
attribut
high
flavonoid
content
particular
presenc
flavonoid
galangin
pinocembrin
huangchin
scutellaria
baicalensi
yet
anoth
exampl
herbal
medicin
use
system
topic
thousand
year
china
treatment
periodont
abscess
infect
oral
wound
flavon
baicalein
report
larg
respons
plant
antimicrobi
effect
oh
oh
oh
naringenin
oh
oh
oh
naringin
oh
oh
pinocembrin
oh
oh
ponciretin
oh
oh
och
sophoraflavanon
g
oh
oh
oh
oh
ch
butenyl
flavanon
h
r
h
c
h
h
chalcon
licochalcon
oh
och
h
licochalcon
c
oh
och
h
trihydroxychalcon
oh
oh
h
methylchalcon
oh
oh
ch
h
oh
oh
oh
oh
oh
oh
pelargonidin
chlorid
cl
oh
oh
oh
flavan
dichloroflavan
c
l
c
l
methylenedioxi
flavan
h
suggest
flavonoid
wide
distribut
edibl
plant
beverag
previous
use
tradit
medicin
like
minim
toxic
howev
famili
compound
divers
rang
activ
mammalian
cell
vivo
confirm
side
effect
would
necessari
full
evalu
practic
use
field
modern
medicin
given
select
flavonoid
eukaryot
enzym
appear
vari
compound
compound
studi
would
need
assess
toxic
phytochem
individu
basi
owe
widespread
abil
flavonoid
inhibit
spore
germin
plant
pathogen
propos
use
fungal
pathogen
man
new
prenyl
flavanon
recent
isol
shrub
eysenhardtia
texana
identifi
flavanon
shown
possess
activ
opportunist
pathogen
candida
albican
flavonoid
methylenedioxi
flavan
isol
terminalia
bellerica
fruit
rind
also
shown
possess
activ
c
albican
two
new
flavon
artemisia
giraldi
identifi
dimethoxyflavon
trimethoxyflavon
togeth
dimethoxyflavon
report
exhibit
activ
aspergillu
flavu
speci
fungi
caus
invas
diseas
immunosuppress
patient
activ
propoli
dermatophyt
candida
spp
attribut
least
partial
high
flavonoid
content
galangin
flavonol
commonli
found
propoli
sampl
shown
inhibitori
activ
aspergillu
tamarii
flavu
cladosporium
sphaerospermum
penicillium
digitatum
penicillium
italicum
recent
area
research
particular
interest
appar
inhibitori
activ
flavonoid
human
immunodefici
viru
hiv
date
investig
involv
work
pandem
strain
enzym
vitro
studi
shown
baicalin
inhibit
infect
replic
inhibit
entri
cell
express
chemokin
coreceptor
antagon
revers
transcriptas
flavon
oglycosid
demonstr
li
colleagu
baicalein
robustaflavon
hinokiflavon
also
shown
inhibit
revers
transcriptas
sever
catechin
catechin
inhibit
dna
polymeras
interact
enzym
therefor
thought
nonspecif
natur
addit
demonstr
sever
flavonoid
includ
demethyl
gardenin
dihydroxyflavon
inhibit
proteinas
robinetin
myricetin
baicalein
quercetagetin
quercetin
galloyl
inhibit
integras
although
concern
hiv
enzym
inhibit
quercetagetin
myricetin
nonspecif
also
report
flavonoid
chrysin
acacetin
apigenin
prevent
activ
via
novel
mechan
probabl
involv
inhibit
viral
transcript
interestingli
studi
hu
colleagu
chrysin
report
highest
therapeut
index
natur
synthet
flavonoid
sever
research
group
investig
relationship
flavonoid
structur
inhibitori
activ
enzym
furthermor
least
two
group
propos
mechan
action
enzym
inhibit
flavonoid
also
inhibitori
activ
varieti
virus
exampl
selway
report
quercetin
morin
rutin
dihydroquercetin
dihydrofisetin
leucocyanidin
pelargonidin
chlorid
catechin
possess
activ
seven
type
viru
includ
herp
simplex
viru
hsv
respiratori
syncyti
viru
polioviru
sindbi
viru
propos
antivir
mechan
action
includ
inhibit
viral
polymeras
bind
viral
nucleic
acid
viral
capsid
protein
addit
flavonoid
mention
three
proanthocyanidin
pavetta
owariensi
structur
similar
proanthocyanidin
cinnamtannin
shown
activ
hsv
coxsacki
b
viru
also
demonstr
two
flavonoid
found
propoli
chrysin
kaempferol
inhibit
viral
replic
hsv
human
coronaviru
rotaviru
recent
flavonol
galangin
report
signific
antivir
activ
hsv
coxsacki
b
viru
although
natur
occur
flavonoid
antivir
activ
recognis
sinc
last
year
attempt
made
synthet
modifi
flavonoid
improv
antivir
activ
one
synthesis
compound
dichloroflavan
howev
despit
show
strong
vitro
activ
compound
prove
unsuccess
clinic
trial
synerg
demonstr
variou
combin
flavon
flavonol
exampl
kaempferol
luteolin
show
synergi
hsv
suggest
propoli
activ
individu
compon
compound
synerg
also
report
flavonoid
antivir
agent
quercetin
exampl
potenti
effect
dioxyuridin
acyclovir
hsv
pseudorabi
infect
apigenin
also
enhanc
antivir
activ
acyclovir
virus
antibacteri
activ
flavonoid
increasingli
document
crude
extract
plant
histori
use
folk
medicin
screen
vitro
antibacteri
activ
mani
research
group
flavonoidrich
plant
extract
speci
hypericum
capsella
chromolaena
report
possess
antibacteri
activ
mani
phytochem
prepar
high
flavonoid
content
also
report
exhibit
antibacteri
activ
propoli
analys
mani
occas
sampl
contain
high
concentr
flavonoid
frequent
report
show
antibacteri
activ
mani
research
group
gone
one
step
either
isol
identifi
structur
flavonoid
possess
antibacteri
activ
quantifi
activ
commerci
avail
flavonoid
exampl
flavonoid
apigenin
galangin
pinocembrin
ponciretin
genkwanin
sophoraflavanon
g
deriv
naringin
naringenin
epigallocatechin
gallat
deriv
luteolin
luteolin
quercetin
variou
quercetin
glycosid
kaempferol
deriv
flavon
flavon
glycosid
isoflavon
flavanon
isoflavanon
isoflavan
flavonol
flavonol
glycosid
chalcon
antibacteri
activ
also
identifi
research
report
synergi
natur
occur
flavonoid
antibacteri
agent
resist
strain
bacteria
exampl
includ
epicatechin
gallat
sophoraflavanon
g
least
one
group
demonstr
synergi
flavonoid
antibacteri
activ
other
synthet
modifi
natur
flavon
analys
antibacteri
activ
exampl
wang
colleagu
complex
dimethoxyflavon
number
transit
metal
shown
process
increas
antibacteri
activ
anoth
group
report
increas
antibacteri
activ
b
ring
contain
bromin
chlorin
substitu
two
research
group
describ
use
flavonoid
vivo
studi
vijaya
ananthan
oral
administr
either
mgkg
quercetin
mgkg
quercetrin
protect
guinea
pig
induc
shigella
infect
kill
untreat
control
anim
recent
dastidar
cowork
report
intraperiton
inject
either
mgkg
sophoraisoflavon
mgkg
gave
signific
protect
mice
challeng
colonyform
unit
cfu
salmonella
typhimurium
report
antibacteri
activ
flavonoid
compar
result
appear
wide
conflict
tabl
exampl
publish
apigenin
activ
aureu
concentr
gml
separ
studi
year
report
flavon
inhibit
growth
strain
mrsa
sensit
strain
aureu
concentr
gml
tabl
inhibitori
activ
apigenin
numer
speci
gramposit
dd
disk
diffus
assay
bmad
broth
macrodilut
assay
bmid
broth
microdilut
assay
ns
assay
type
state
report
awd
agar
well
diffus
assay
ad
agar
dilut
assay
antibacteri
activ
detect
antibacteri
activ
detect
gml
tabl
seen
discrep
could
perhap
attribut
occas
differ
assay
use
eg
mani
differ
assay
employ
flavonoid
research
includ
agar
dilut
techniqu
paper
disk
diffus
assay
holepl
diffus
method
cylind
diffus
method
broth
macrodilut
techniqu
broth
microdilut
techniqu
particular
assay
reli
diffus
test
flavonoid
may
give
reliabl
quantit
measur
antibacteri
activ
potent
antibacteri
flavonoid
may
low
rate
diffus
howev
clear
tabl
addit
factor
involv
caus
discrep
even
group
use
assay
obtain
conflict
result
eg
inconsist
may
due
variat
within
assay
exampl
differ
group
use
agar
dilut
techniqu
use
differ
size
bacteri
inoculum
report
nation
committe
clinic
laboratori
standard
nccl
inoculum
size
consid
singl
import
variabl
suscept
test
note
mani
group
assay
flavonoid
antibacteri
activ
quantifi
test
bacteri
suspens
other
even
standardis
size
unenumer
inocula
publish
work
clear
addit
inoculum
size
mani
variabl
factor
type
assay
includ
volum
broth
agar
type
broth
agar
size
well
size
paper
disk
strain
particular
bacteri
speci
use
incub
period
recent
set
guidelin
publish
standard
agar
dilut
broth
macrodilut
broth
microdilut
method
may
help
reduc
number
conflict
report
flavonoid
antibacteri
activ
futur
howev
remain
necessari
consid
care
addit
variabl
solvent
use
dissolv
test
flavonoid
previous
shown
precipit
occur
select
flavonoid
dissolv
organ
solvent
dilut
neutral
polar
solut
precipit
flavonoid
minimum
inhibitori
concentr
mic
assay
like
caus
diminish
contact
bacteri
cell
flavonoid
molecul
may
lead
fals
neg
report
antibacteri
activ
also
improperli
control
experi
flavonoid
precipit
could
misinterpret
bacteri
growth
fals
neg
result
may
record
consequ
structur
alter
flavonoid
galangin
alkalin
solvent
anoth
matter
consider
flavonoid
salt
form
increas
decreas
potenc
compar
parent
structur
may
lead
fals
positiveneg
report
antibacteri
activ
variabl
worth
note
includ
whether
test
flavonoid
obtain
commerci
natur
sourc
compani
natur
product
compound
divers
rang
cell
function
affect
flavonoid
eukaryot
system
well
document
although
compar
studi
mechan
underli
flavonoid
antibacteri
activ
inform
publish
literatur
indic
differ
compound
within
class
phytochem
may
target
differ
compon
function
bacteri
cell
case
surpris
small
number
group
investig
relationship
flavonoid
structur
antibacteri
activ
summaris
abl
identifi
common
structur
featur
among
activ
compound
howev
may
individu
antibacteri
flavonoid
multipl
cellular
target
rather
one
specif
site
action
altern
common
structur
featur
may
simpli
necessari
flavonoid
gain
proxim
uptak
bacteri
cell
tsuchiya
colleagu
sought
establish
structureact
relationship
flavanon
isol
number
differ
substitut
compound
determin
mic
mrsa
studi
indic
dihydroxyl
b
ring
ring
flavanon
structur
import
antimrsa
activ
substitut
posit
long
chain
aliphat
group
lavandulyl
geranyl
also
enhanc
activ
interestingli
recent
report
stapleton
colleagu
demonstr
substitut
c
c
chain
also
enhanc
antistaphylococc
activ
flavonoid
belong
class
osawa
et
al
assess
activ
number
structur
differ
flavonoid
includ
flavon
flavanon
isoflavon
isoflavanon
base
paper
disk
agar
diffus
assay
shown
one
two
three
addit
hydroxyl
group
posit
inhibit
growth
streptococcu
mutan
streptococcu
sobrinu
result
correl
well
tsuchiya
colleagu
also
report
osawa
colleagu
addit
hydroxyl
group
posit
exhibit
inhibitori
activ
howev
sato
et
al
examin
two
isoflavon
hydroxyl
group
posit
use
agar
dilut
assay
intens
inhibitori
activ
detect
wide
rang
streptococc
speci
may
suggest
hydroxyl
posit
import
activ
altern
lack
activ
detect
osawa
et
al
may
simpli
due
poor
diffus
flavon
isoflavon
compar
flavanon
isoflavanon
medium
recent
paper
also
report
import
hydroxyl
group
posit
flavanon
flavon
activ
mrsa
support
earlier
find
tsuchiya
et
al
state
chalcon
effect
mrsa
flavanon
flavon
hydroxyl
group
posit
import
antistaphylococc
activ
compound
methoxi
group
report
drastic
decreas
antibacteri
activ
flavonoid
import
hydroxyl
posit
antibacteri
activ
chalcon
support
earlier
work
sato
colleagu
found
methylchalcon
inhibit
growth
strain
cariogen
streptococci
mention
previous
ward
colleagu
synthesis
number
halogen
deriv
substitut
b
ring
found
enhanc
antibacteri
activ
chloro
bromo
analogu
approxim
twice
effect
parent
compound
aureu
four
time
activ
enterococcu
faecali
also
dichloro
deriv
exhibit
fourto
eightfold
improv
activ
aureu
twoto
fourfold
improv
e
faecali
contrast
less
potent
parent
compound
author
suggest
halogen
ring
may
diminish
activ
clearli
howev
would
necessari
prepar
analogu
substitut
are
posit
could
said
certainti
chalcon
neither
fluorin
chlorin
posit
b
ring
report
affect
antibacteri
potenc
significantli
howev
structur
analogu
class
flavonoid
would
need
synthesis
examin
effect
halogen
upon
antibacteri
activ
could
properli
assess
sever
research
group
attempt
determin
whether
flavonoid
activ
bacteriostat
bactericid
conduct
timekil
studi
experi
epigallocatechin
gallat
galangin
catechin
shown
caus
reduct
viabl
count
mrsayk
aureu
nctc
respect
would
immedi
appear
suggest
flavonoid
capabl
bactericid
activ
howev
recent
demonstr
epicatechin
induc
format
pseudomulticellular
aggreg
antibioticsensit
antibioticresist
strain
aureu
phenomenon
induc
compound
within
flavonoid
class
liposom
studi
suggest
case
epigallocatechin
gallat
question
rais
regard
interpret
result
timekil
studi
may
flavonoid
kill
bacteri
cell
mere
induc
format
bacteri
aggreg
therebi
reduc
number
cfu
viabl
count
studi
use
radioact
precursor
mori
colleagu
show
dna
synthesi
strongli
inhibit
flavonoid
proteu
vulgari
whilst
rna
synthesi
affect
aureu
flavonoid
exhibit
activ
robinetin
myricetin
epigallocatechin
protein
lipid
synthesi
also
affect
lesser
extent
author
suggest
b
ring
flavonoid
may
play
role
intercal
hydrogen
bond
stack
nucleic
acid
base
may
explain
inhibitori
action
dna
rna
synthesi
ohemeng
et
al
screen
flavonoid
vari
structur
inhibitori
activ
escherichia
coli
dna
gyras
antibacteri
activ
staphylococcu
epidermidi
aureu
e
coli
typhimurium
stenotrophomona
maltophilia
found
e
coli
dna
gyras
inhibit
differ
extent
seven
compound
includ
quercetin
apigenin
interestingli
except
enzym
inhibit
limit
compound
bring
hydroxyl
author
propos
observ
antibacteri
activ
seven
flavonoid
due
part
inhibit
dna
gyras
howev
sinc
level
antibacteri
activ
enzym
inhibit
alway
correl
also
suggest
mechan
involv
recent
plaper
colleagu
report
quercetin
bind
gyrb
subunit
e
coli
dna
gyras
inhibit
enzym
atpas
activ
enzym
bind
demonstr
isol
e
coli
dna
gyras
measur
quercetin
fluoresc
presenc
absenc
gyras
subunit
flavonoidbind
site
postul
overlap
atp
novobiocin
sinc
addit
compound
interf
quercetin
fluoresc
inhibit
gyrb
atpas
activ
quercetin
also
demonstr
coupl
atpas
assay
research
agreement
earlier
find
ohemeng
et
al
support
suggest
quercetin
antibacteri
activ
e
coli
may
least
partial
attribut
inhibit
dna
gyras
screen
natur
product
type
ii
topoisomeras
inhibitor
bernard
cowork
found
glycosyl
flavonol
rutin
effect
compound
exhibit
antibacteri
activ
permeabl
e
coli
strain
strain
allel
incorpor
use
enzym
assay
techniqu
known
so
chromotest
shown
rutin
select
promot
e
coli
topoisomeras
ivdepend
dna
cleavag
inhibit
topoisomeras
ivdepend
decaten
activ
induc
so
respons
e
coli
strain
group
suggest
sinc
topoisomeras
iv
essenti
cell
surviv
rutininduc
topoisomeras
ivmedi
dna
cleavag
lead
so
respons
growth
inhibit
e
coli
cell
within
laboratori
aureu
strain
shown
increas
suscept
flavonol
galangin
compar
resist
strain
interestingli
strain
possess
distinct
amino
acid
substitut
serin
prolin
posit
grlb
subunit
may
suggest
topoisomeras
iv
rel
homolog
gyras
enzym
involv
antibacteri
mechan
action
galangin
clearli
howev
work
mutant
strain
purifi
enzym
would
necessari
could
verifi
research
team
previous
found
sophoraflavanon
g
intens
antibacteri
activ
mrsa
streptococci
recent
report
attempt
elucid
mechan
action
flavanon
effect
sophoraflavanon
g
membran
fluiditi
studi
use
liposom
model
membran
compar
less
activ
flavanon
naringenin
lack
hydroxyl
group
concentr
correspond
mic
valu
sophoraflavanon
g
shown
increas
fluoresc
polaris
liposom
significantli
increas
indic
alter
membran
fluiditi
hydrophil
hydrophob
region
suggest
sophoraflavanon
g
reduc
fluiditi
outer
inner
layer
membran
naringenin
also
exhibit
membran
effect
much
higher
concentr
correl
antibacteri
activ
membran
interfer
suggest
support
theori
sophoraflavanon
g
demonstr
antibacteri
activ
reduc
membran
fluiditi
bacteri
cell
anoth
group
ikigai
colleagu
carri
research
epigallocatechin
gallat
strongli
antibacteri
catechin
found
green
tea
catechin
group
flavonoid
appear
greater
activ
gramposit
gramneg
bacteria
studi
liposom
use
model
bacteri
membran
shown
epigallocatechin
gallat
induc
leakag
small
molecul
intraliposom
space
aggreg
also
note
liposom
treat
compound
group
therefor
conclud
catechin
primarili
act
damag
bacteri
membran
known
damag
occur
two
theori
put
forward
first
catechin
may
perturb
lipid
bilay
directli
penetr
disrupt
barrier
function
altern
catechin
may
caus
membran
fusion
process
result
leakag
intramembran
materi
aggreg
interestingli
group
also
demonstr
leakag
induc
epigallocatechin
gallat
significantli
lower
liposom
membran
prepar
contain
neg
charg
lipid
therefor
suggest
low
catechin
suscept
gramneg
bacteria
may
least
partial
attribut
presenc
lipopolysaccharid
act
barrier
mention
previous
stapleton
colleagu
found
substitut
c
c
chain
increas
antibacteri
activ
select
catechin
group
went
show
cell
mrsa
clinic
isol
treat
epicatechin
gallat
catechin
respect
exhibit
moder
highli
increas
level
label
select
permeabl
fluoresc
stain
propidium
iodid
addit
aureu
cell
grown
presenc
either
epicatechin
gallat
epicatechin
examin
transmiss
electron
microscopi
shown
form
pseudomulticellular
aggreg
work
constitut
substanti
advanc
develop
catechin
antibacteri
agent
lend
support
ikigai
argument
catechin
act
damag
bacteri
membran
also
demonstr
sato
colleagu
chalcon
methylchalcon
induc
leakag
nm
absorb
substanc
mutan
observ
gener
indic
leakag
intracellular
materi
nucleotid
author
suggest
methylchalcon
exert
antibacteri
effect
chang
permeabl
cellular
membran
damag
membran
function
addit
effect
galangin
upon
cytoplasm
integr
aureu
investig
measur
loss
intern
potassium
high
cell
densiti
aureu
incub
h
media
contain
gml
flavonol
decreas
number
cfu
note
cell
lost
ca
potassium
untreat
control
bacteria
data
strongli
suggest
galangin
induc
cytoplasm
membran
damag
potassium
leakag
whether
galangin
damag
membran
directli
indirectli
result
autolysi
cell
wall
damag
osmot
lysi
remain
establish
howev
investig
antimicrobi
action
propoli
mirzoeva
colleagu
show
one
constitu
flavonoid
quercetin
caus
increas
permeabl
inner
bacteri
membran
dissip
membran
potenti
electrochem
gradient
proton
across
membran
essenti
bacteria
maintain
capac
atp
synthesi
membran
transport
motil
mirzoeva
et
al
suggest
effect
propoli
membran
permeabl
membran
potenti
may
contribut
enorm
overal
antibacteri
activ
may
decreas
resist
cell
antibacteri
agent
thought
might
explain
synergist
effect
occur
propoli
antibiot
tetracyclin
ampicillin
group
also
demonstr
flavonoid
quercetin
naringenin
significantli
inhibit
bacteri
motil
provid
evid
proton
motiv
forc
disrupt
bacteri
motil
chemotaxi
thought
import
virul
guid
bacteria
site
adher
invas
mirzoeva
et
al
suggest
antimotil
action
propoli
compon
may
import
role
inhibit
bacteri
pathogenesi
develop
infect
cytoplasm
membran
activ
detect
quercetin
mirzoeva
cowork
may
repres
one
addit
mechan
antibacteri
action
suspect
present
among
seven
dna
gyraseinhibit
flavonoid
compound
test
ohemeng
colleagu
haraguchi
colleagu
recent
carri
investig
antibacteri
mode
action
two
retrochalcon
licochalcon
c
root
glycyrrhiza
inflata
flavonoid
demonstr
inhibitori
activ
aureu
micrococcu
luteu
e
coli
preliminari
test
licochalcon
inhibit
incorpor
radioact
precursor
macromolecul
dna
rna
protein
group
hypothesis
licochalcon
may
interf
energi
metabol
similar
way
respiratoryinhibit
antibiot
sinc
energi
requir
activ
uptak
variou
metabolit
biosynthesi
macromolecul
interestingli
licochalcon
found
inhibit
strongli
oxygen
consumpt
luteu
aureu
e
coli
correl
well
observ
spectrum
antibacteri
activ
group
demonstr
licochalcon
c
effect
inhibit
nadhcytochrom
c
reductas
cytochrom
c
oxidas
nadhcoq
reductas
therefor
suggest
inhibit
site
retrochalcon
coq
cytochrom
c
bacteri
respiratori
electron
transport
chain
merck
research
laboratori
recent
report
flavanon
lonchocarpol
inhibit
macromolecular
synthesi
bacillu
megaterium
use
radioact
precursor
demonstr
rna
dna
cell
wall
protein
synthesi
inhibit
concentr
similar
mic
valu
may
repres
anoth
exampl
flavonoid
interfer
energi
metabol
regard
natur
product
gener
accept
phytochem
less
potent
antiinfect
agent
microbi
origin
ie
antibiot
howev
new
class
antimicrobi
drug
urgent
requir
flavonoid
repres
novel
set
lead
futur
optimis
compound
structur
alter
may
allow
develop
pharmacolog
accept
antimicrobi
agent
group
agent
exist
structureact
data
suggest
might
possibl
exampl
prepar
potent
antibacteri
flavanon
synthesis
compound
halogen
b
ring
well
lavandulyl
geranyl
substitut
ring
also
worth
note
rapid
progress
made
toward
elucid
flavonoid
biosynthet
pathway
may
soon
allow
product
structur
analogu
activ
flavonoid
genet
manipul
screen
analogu
might
lead
identif
compound
suffici
potent
use
antifung
antivir
antibacteri
chemotherapeut
addit
structur
alter
weak
moder
activ
antimicrobi
flavonoid
investig
mechan
action
compound
like
product
area
research
inform
may
assist
optimis
lead
compound
activ
provid
focu
toxicolog
attent
aid
anticip
resist
also
characteris
interact
antimicrobi
flavonoid
target
site
could
potenti
allow
design
secondgener
inhibitor
